South Korea Cardiac Assist Devices Market Insight
Published: 27 June 2026 | Report Format: Electronic (PDF) | Author: Govind and Krishna
The market for cardiac assist devices in South Korea is anticipated to increase at a compound yearly growth rate of 13.68% due to the rising prevalence of cardiovascular illnesses.
South Korea Cardiac Assist Devices Market Insights Forecasts to 2035
- The South Korea Cardiac Assist Devices Market Size Was Estimated USD 72.3 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 13.68% from 2025 to 2035
- The South Korea Cardiac Assist Devices Market Size is Expected to rise around USD 260.7 Million by 2035
Notable Insights for the South Korea Cardiac Assist Devices Market
- When it comes to bridge-to-transplant or destination therapy, Ventricular Assist Devices (VADs) are the most popular product type. Short-term circulatory support devices and intra-aortic balloon pumps are also quite popular for acute interventions and hemodynamic support.
- According to application segmentation, bridge to transplant is the most prevalent application due to lack of donor hearts. Destination therapy is emerging as a result of increased durability of VADs. The pediatric application constitutes small but significant segment within this market.
- The South Korean government has been covering VAD operations through their national health insurance since September 2018. There have been 465 LVAD and 43 EXCOR VAD procedures from 2018 to 2023, with 1-year survival being 83.
- Key companies operating in South Korea include Abbott, Medtronic, and Berlin Heart GmbH. This market is boosted by positive payment policies and innovative durable implants, earning considerable revenue due to the widespread occurrence of heart failure and cardiac centers.
Download the eBook (ToC)
Why Buy This Report
- It provides historical data, current valuation, and projections for the cardiac assist devices market in South Korea through 2033 to help strategic decisions.
- Get trustworthy market projections that help investors reduce risks and maximize long-term business and investment returns. These forecasts are backed by solid research methods, original interviews, secondary research, and quantitative analysis.
- Determine developing technologies that allow businesses to effectively take advantage of changing clinical and commercial prospects, such as ventricular assist devices, extracorporeal membrane oxygenation systems, and next-generation cardiac support advances.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea Cardiac Assist Devices Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in South Korea Cardiac Assist Devices Market
- Abiomed Inc
- Abbott Laboratories
- LivaNova Plc
- Medtronic Plc
- Getinge AB
- Teleflex Inc
- Terumo Corp
- Berlin Heart GmbH
- Jarvik Heart, Inc.
- ReliantHeart Inc.
Recent Developments:
- In October 2025, in order to promote clinical research on its HeartMate 3 LVAD for destination therapy in the Asian population, Abbott Laboratories announced a partnership with a South Korean medical facility.
- In July 2025, with an integrated driver and enhanced mobility for young patients awaiting transplantation, tokyo Heart GmbH unveiled its innovative EXCOR Active pediatric VAD system in Germany.
Market Segmentation:
South Korea Cardiac Assist Devices Market, By Modality
- Implantable Devices
- Transcutaneous/External Devices
South Korea Cardiac Assist Devices Market, By Application
- Bridge-to-Transplant (BTT)
- Destination Therapy (DT)
- Bridge-to-Recovery (BTR)
South Korea Cardiac Assist Devices Market, By End-User
- Hospitals
- Cardiac Centers
- Ambulatory Surgical Centers
Expert Views:
Market growth in South Korea’s cardiac assist devices industry can be forecasted in the coming years due to the rising incidence of heart failure conditions, positive reimbursement scenario, and rising adoption of ventricular assist devices for bridge-to-transplant and destination therapy treatments. Developments in technology and improvements in device performance, along with clinical expertise and increased awareness, will contribute to the leadership of South Korea’s advanced mechanical circulatory support market through 2035.
Author: Govind and Krishna By Decisions Advisors and Consulting